Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to […]

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior energy firms UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve Nuclear energy included […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44% CNSP has sublicensed Berubicin to WPD Pharmaceuticals in […]

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

Telehealth sector going through explosive growth; patients’ data protection remains key challenge Although relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients’ data security, privacy likely to tighten as pandemic abates RYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting Telehealth is becoming increasingly popular with patients […]

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Positioned to Benefit as Studies Find CBD Oil Could Help Treat COVID-19 Effects

Medical College of Georgia research shows beneficial effects from use of CBD oil to treat COVID-19 symptoms CBD oil found to increase apelin levels in the human body, a key peptide needed to reduce lung inflammation resulting from COVID-19 PacRoots Cannabis specializes in developing premium quality strains, including plants with high CBD content, rare terpene […]

SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity

Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns Sequire subscriber base surged to 3 million active traders across 90 public companies since its 2019 inception Investor interest sent […]

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics […]

Brain Scientific (BRSF) Developing State-of-the-Art AI Diagnostic Analytics

BRSF working to improve diagnostics by leveraging AI and machine learning Cloud-based infrastructure, AI-assisted diagnostic analysis is in development phase Brain Scientific creating long-term monitoring capabilities that leads to collection of essential biomarkers Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, is working on developing […]

Asia Broadband Inc. (AABB) Is ‘One to Watch’

Asia Broadband Inc. is focused on the production, supply and sale of precious and base metals, primarily to Asian markets The company recently acquired a high potential mineral property in the state of Colima, Mexico Asia Broadband has teamed with crypto wallet creator Core State Holdings Corp. to develop the AABB Gold token, a gold-backed […]

 

From Our Blog

SS Innovations International Inc. (NASDAQ: SSII) Strengthens Leadership as Global Robotic Surgery Expansion Gains Pace

July 17, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, adding public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives. The appointment, effective August 3, comes at a time […]

Rotate your device 90° to view site.